Zimmer Biomet received FDA Premarket Approval Application Supplement approval for the Oxford Cementless Partial Knee implant.
The implant is the only FDA-approved cementless partial knee implant in the U.S., according to a Nov. 25 news release.
The Oxford Cementless Partial Knee has been used in more than 300,000 procedures across Canada, Europe, Middle East, Africa and Asia.
A cementless approach allows patients' natural bone growth to secure the implant for better long-term fixation.
The Oxford Partial Knee provides a limited lifetime warranty to patients in the U.S. that covers the cost of Zimmer Biomet replacement implants.
The implant system will launch in the U.S. during the first quarter of 2025, the release said.